No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
105754083 : the E&Y report is nothing new.. pharma has the same concern since 2023 when they were declared pn17.. until pn17 resolved, same concern will be declared by any auditor
pn17 is progressing well.. latest EGM approved the plan, should get some update soon coz they said previously target to raise the funds in Q2...